The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2016

Filed:

Mar. 05, 2014
Applicants:

Institut Pasteur, Paris, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Theravectys, Villejuif, FR;

Inventors:

Pierre Charneau, Paris, FR;

Anne-Sophie Beignon, Paris, FR;

Frederic Philippe Coutant, Rodez, FR;

Karine Courbeyrette, Massy, FR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/21 (2006.01); C07K 14/005 (2006.01); C07K 16/10 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); C07K 16/10 (2013.01); C07K 16/1054 (2013.01); C07K 16/1081 (2013.01); C12N 15/86 (2013.01); A61K 2039/505 (2013.01); A61K 2039/525 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/76 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15034 (2013.01); C12N 2740/15043 (2013.01); C12N 2740/16222 (2013.01); C12N 2760/20222 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24134 (2013.01); C12N 2810/6081 (2013.01);
Abstract

The present invention relates to the design of gene transfer vectors and especially provides lentiviral gene transfer vectors suitable for either a unique administration or for iterative administration in a host, and to their medicinal application (such as vaccination against Immunodeficiency Virus, especially suitable in human hosts). Gene transfer vectors can be either integrative or non-integrative vectors. The invention encompasses prophylactic, therapeutic, symptomatic, and curative treatments of animals, including humans, as well as gene therapy and vaccination in vivo.


Find Patent Forward Citations

Loading…